LONNY ELSON: Open Payments
NPI 1912192048 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 26 payments from 10 companies in 2025. Trend: 2023 $161 · 2024 $1,025 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| ABBVIE INC. | 7 | $144 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Eisai Inc. | 2 | $51 |
| EMD Serono, Inc. | 2 | $50 |
| Viatris Specialty LLC | 1 | $31 |
| UCB, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
Products named: QULIPTA, BREZTRI, Xeomin, Leqembi, AIRSUPRA, YUPELRI, Rystiggo, UBRELVY.
Industry payments across AZ — which companies pay providers there.
